Abhijit Kulkarni
Overview
Explore the profile of Abhijit Kulkarni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khataniar H, Habib H, Ruiz M, Dharia A, Magoo S, Kulkarni A
ACG Case Rep J
. 2025 Mar;
12(3):e01641.
PMID: 40084063
Eosinophilic cholangitis (EC) is a rare condition characterized by eosinophilic infiltration of the bile ducts, often mimicking diseases like primary sclerosing cholangitis or cholangiocarcinoma. We report the case of a...
2.
Shamanna P, Maheshwari A, Keshavamurthy A, Bhat S, Kulkarni A, R S, et al.
AACE Clin Case Rep
. 2025 Feb;
11(1):70-74.
PMID: 39896947
Background: Clinical manifestations of polycystic ovary syndrome (PCOS) are heterogeneous, with hallmarks including anovulation, androgen excess, and insulin resistance. Case Report: A 38-year-old female with typical PCOS features presented with...
3.
Quach A, Lao Y, Troelnikov A, Hissaria P, Chan D, Wells A, et al.
J Allergy Clin Immunol
. 2025 Feb;
PMID: 39891630
No abstract available.
4.
Iyer V, Saberi S, Pacheco R, Sizemore E, Stockman S, Kulkarni A, et al.
Neuropharmacology
. 2024 Jun;
257:110052.
PMID: 38936657
The direct blockade of CB cannabinoid receptors produces therapeutic effects as well as adverse side-effects that limit their clinical potential. CB negative allosteric modulators (NAMs) represent an indirect approach to...
5.
Wani S, Cote G, Keswani R, Yadlapati R, Hall M, OHara J, et al.
Gastrointest Endosc
. 2024 Jun;
101(1):12-24.
PMID: 38935016
Background And Aims: Training in interventional endoscopy is offered by nonaccredited advanced endoscopy fellowship programs (AEFPs). The number of these programs has increased dramatically with a concurrent increase in the...
6.
Iyer V, Saberi S, Pacheco R, Sizemore E, Stockman S, Kulkarni A, et al.
bioRxiv
. 2024 Jan;
PMID: 38260598
Highlights: CB negative allosteric modulator (NAM) GAT358 attenuated morphine tolerance GAT358 reduced morphine-induced slowing of colonic motility but not fecal productionGAT358 was antinociceptive for formalin pain alone and when combined...
7.
Shah N, Kulkarni A, Mongad D, Jaani K, Kajale N, Tamahane V, et al.
Indian J Endocrinol Metab
. 2023 Dec;
27(5):404-409.
PMID: 38107732
Background: Non-genetic factors like microbial dysbiosis may be contributing to the increasing incidence/progression of type 1 diabetes mellitus (T1DM). Objectives: To analyse the gut microbiota profile in Indian children with...
8.
Karna R, Jagdish B, Mohy-Ud-Din N, Kulkarni A
ACG Case Rep J
. 2023 Sep;
10(9):e01132.
PMID: 37663237
An arteriovenous-enteric fistula is a 3-way connection between the vascular and enteric system and associated with high mortality. We describe a case of iliac artery-inferior vena cava-duodenal fistula in a...
9.
Gauthier A, Lin M, Zefi S, Kulkarni A, Thakur G, Ashby Jr C, et al.
Redox Biol
. 2023 Jan;
60:102614.
PMID: 36717349
Supraphysiological concentrations of oxygen (hyperoxia) can compromise host defense and increase susceptibility to bacterial and viral infections, causing ventilator-associated pneumonia (VAP). Compromised host defense and inflammatory lung injury are mediated,...
10.
Iyer V, Rangel-Barajas C, Woodward T, Kulkarni A, Cantwell L, Crystal J, et al.
Pharmacol Res
. 2022 Sep;
185:106474.
PMID: 36179954
Blockade of cannabinoid type 1 (CB)-receptor signaling decreases the rewarding properties of many drugs of abuse and has been proposed as an anti-addiction strategy. However, psychiatric side-effects limit the clinical...